2021 Annual Meeting Knee Access Pass-Questions and Answers: Session B: Meniscus

Video Transcription

Video Summary

The video features a panel discussion with Dr. Gershoff and other authors regarding a series of papers on meniscal implantation. Dr. Gershoff discusses the reoperation rate mentioned in the paper, noting that it was high but can be attributed to factors such as surgical technique improvements and patient non-compliance. He also mentions revisions in the design and technique of the implant, indicating that revisions in technique have been made. The panel also discusses activity restrictions after implantation and the potential introduction of the implant in the United States, awaiting FDA approval. The cost is uncertain at the moment. The conversation then shifts to the possibility of meniscus tibial ligament repair and addressing residual extrusion. The limitations of data from the Kaiser system are acknowledged, and indications for root repair are discussed, considering the better outcomes compared to non-op or partial meniscectomy. Overall, the video provides insights into the reoperation rate, technique improvements, activity restrictions, FDA approval process, and the potential future directions for meniscal implantation.

Asset Caption

Daniel Kaplan, MD; Mario Hevesi, MD; David Ding, MD; William Cregar, MD; Wayne Gersoff, MD

Keywords

meniscal implantation

reoperation rate

surgical technique improvements

FDA approval

root repair